147 related articles for article (PubMed ID: 29795181)
1. Low doses of bioherbicide favour prion aggregation and propagation in vivo.
Lafon PA; Imberdis T; Wang Y; Torrent J; Robitzer M; Huetter E; Alvarez-Martinez MT; Chevallier N; Givalois L; Desrumaux C; Liu J; Perrier V
Sci Rep; 2018 May; 8(1):8023. PubMed ID: 29795181
[TBL] [Abstract][Full Text] [Related]
2. A Fluorescent Oligothiophene-Bis-Triazine ligand interacts with PrP fibrils and detects SDS-resistant oligomers in human prion diseases.
Imberdis T; Ayrolles-Torro A; Duarte Rodrigues A; Torrent J; Alvarez-Martinez MT; Kovacs GG; Verdier JM; Robitzer M; Perrier V
Mol Neurodegener; 2016 Jan; 11():11. PubMed ID: 26809712
[TBL] [Abstract][Full Text] [Related]
3. Oligomeric-induced activity by thienyl pyrimidine compounds traps prion infectivity.
Ayrolles-Torro A; Imberdis T; Torrent J; Toupet K; Baskakov IV; Poncet-Montange G; Grégoire C; Roquet-Baneres F; Lehmann S; Rognan D; Pugnière M; Verdier JM; Perrier V
J Neurosci; 2011 Oct; 31(42):14882-92. PubMed ID: 22016521
[TBL] [Abstract][Full Text] [Related]
4. The N-terminal, polybasic region of PrP(C) dictates the efficiency of prion propagation by binding to PrP(Sc).
Turnbaugh JA; Unterberger U; Saá P; Massignan T; Fluharty BR; Bowman FP; Miller MB; Supattapone S; Biasini E; Harris DA
J Neurosci; 2012 Jun; 32(26):8817-30. PubMed ID: 22745483
[TBL] [Abstract][Full Text] [Related]
5. Prion Protein Devoid of the Octapeptide Repeat Region Delays Bovine Spongiform Encephalopathy Pathogenesis in Mice.
Hara H; Miyata H; Das NR; Chida J; Yoshimochi T; Uchiyama K; Watanabe H; Kondoh G; Yokoyama T; Sakaguchi S
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046443
[TBL] [Abstract][Full Text] [Related]
6. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
Sasaki K; Minaki H; Iwaki T
J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
[TBL] [Abstract][Full Text] [Related]
7. Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease.
Meier P; Genoud N; Prinz M; Maissen M; Rülicke T; Zurbriggen A; Raeber AJ; Aguzzi A
Cell; 2003 Apr; 113(1):49-60. PubMed ID: 12679034
[TBL] [Abstract][Full Text] [Related]
8. Dissociation of infectivity from seeding ability in prions with alternate docking mechanism.
Miller MB; Geoghegan JC; Supattapone S
PLoS Pathog; 2011 Jul; 7(7):e1002128. PubMed ID: 21779169
[TBL] [Abstract][Full Text] [Related]
9. Copper binding to PrPC may inhibit prion disease propagation.
Hijazi N; Shaked Y; Rosenmann H; Ben-Hur T; Gabizon R
Brain Res; 2003 Dec; 993(1-2):192-200. PubMed ID: 14642846
[TBL] [Abstract][Full Text] [Related]
10. Potent prion-like behaviors of pathogenic α-synuclein and evaluation of inactivation methods.
Tarutani A; Arai T; Murayama S; Hisanaga SI; Hasegawa M
Acta Neuropathol Commun; 2018 Apr; 6(1):29. PubMed ID: 29669601
[TBL] [Abstract][Full Text] [Related]
11. [Mechanisms of prion transmission].
Sakaguchi S
Nihon Rinsho; 2007 Aug; 65(8):1391-5. PubMed ID: 17695274
[TBL] [Abstract][Full Text] [Related]
12. Selective neuronal targeting in prion disease.
DeArmond SJ; Sánchez H; Yehiely F; Qiu Y; Ninchak-Casey A; Daggett V; Camerino AP; Cayetano J; Rogers M; Groth D; Torchia M; Tremblay P; Scott MR; Cohen FE; Prusiner SB
Neuron; 1997 Dec; 19(6):1337-48. PubMed ID: 9427256
[TBL] [Abstract][Full Text] [Related]
13. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
[TBL] [Abstract][Full Text] [Related]
14. Chemical induction of misfolded prion protein conformers in cell culture.
Ghaemmaghami S; Ullman J; Ahn M; St Martin S; Prusiner SB
J Biol Chem; 2010 Apr; 285(14):10415-23. PubMed ID: 19955177
[TBL] [Abstract][Full Text] [Related]
15. Oral Prion Neuroinvasion Occurs Independently of PrP
Marshall A; Bradford BM; Clarke AR; Manson JC; Mabbott NA
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021891
[TBL] [Abstract][Full Text] [Related]
16. Prion protein functions and dysfunction in prion diseases.
Sakudo A; Ikuta K
Curr Med Chem; 2009; 16(3):380-9. PubMed ID: 19149584
[TBL] [Abstract][Full Text] [Related]
17. Intermolecular crosslinking of abnormal prion protein is efficiently induced by a primuline-sensitized photoreaction.
Teruya K; Nishizawa K; Oguma A; Sakasegawa Y; Kitamoto T; Doh-Ura K
Biochim Biophys Acta Gen Subj; 2019 Feb; 1863(2):384-394. PubMed ID: 30447252
[TBL] [Abstract][Full Text] [Related]
18. Altered prion protein glycosylation in the aging mouse brain.
Goh AX; Li C; Sy MS; Wong BS
J Neurochem; 2007 Feb; 100(3):841-54. PubMed ID: 17144900
[TBL] [Abstract][Full Text] [Related]
19. The role of rafts in the fibrillization and aggregation of prions.
Pinheiro TJ
Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
[TBL] [Abstract][Full Text] [Related]
20. Anti-PrP antibodies block PrPSc replication in prion-infected cell cultures by accelerating PrPC degradation.
Perrier V; Solassol J; Crozet C; Frobert Y; Mourton-Gilles C; Grassi J; Lehmann S
J Neurochem; 2004 Apr; 89(2):454-63. PubMed ID: 15056288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
